Vizz is the first and only aceclidine-based eye drop to improve near vision in adults with presbyopia. Vizz contracts the ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

The US Food and Drug Administration has approved the first eye drop that can fix near vision, promising to help ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours at a time.

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

The Food and Drug Administration has approved Vizz (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in ...

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free ...